Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Nelson Syndrome

ClinicalTrials.gov lists 2 trials for Nelson Syndrome or a narrower condition beneath it. Novartis Pharmaceuticals has the most among industry and government lead sponsors, with 1.

MeSH D009347 Neoplasms Neoplasm C04 C10 C19 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 2 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Lead sponsors Lead sponsors 1 Serious adverse events in this condition's trials Serious adverse events in this condition's trials 10 Publications Publications 3 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 2 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Lead sponsors Lead sponsors 1 Serious adverse events in this condition's trials Serious adverse events in this condition's trials 10 Publications Publications 3 Rare-disease identity Rare-disease identity 2

Rows recorded per section

2 sections measured, none recorded · 1 not measured yet · 1 not computed

2 of the 2 trials are tagged with Nelson Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Nelson Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Nelson Syndrome trials start? (2)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2011 1
2009 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Nelson Syndrome trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 2 2

How many Nelson Syndrome trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Terminated 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Nelson Syndrome trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Novartis Pharmaceuticals 1

Which serious adverse events do Nelson Syndrome trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Hyperglycaemia 6 1
Nausea 4 1
Hypoglycaemia 3 1
Vomiting 3 1
Abdominal pain 2 1

Showing 5 of 10 adverse events.

Start your 14-day trial Email me all 10 adverse events as a PDF

Which publications cover Nelson Syndrome? (3)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
A prospective longitudinal study of Pasireotide in Nelson's syndrome. Pituitary 2018 Yes
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. The Journal of clinical endocrinology and metabolism 2008 No
NIH conference. Clinical applications of corticotropin-releasing factor. Annals of internal medicine 1985 No

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Nelson syndrome 199244 Exact Orphanet Rare Disease Ontology (ORDO)
Nelson syndrome 199244 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages